Osteoinduction by bone morphogenetic protein 2-expressing adenoviral vector: Application of biomaterial to mask the host immune response

Human Gene Therapy

Volumn 15, Issue 7, 2004, Pages 659-668

  Sonobe, Junya ^a   Okubo, Yasunori ^a   Kaihara, Shinji ^a   Miyatake, Shin Ichi ^b   Bessho, Kazuhisa ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; COLLAGEN TYPE 1; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE RADIOGRAPHY; CONTROLLED STUDY; DNA VECTOR; GASTROCNEMIUS MUSCLE; GENE DELIVERY SYSTEM; GENE EXPRESSION; HISTOLOGY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; MALE; MASKING; NONHUMAN; OSSIFICATION; PLASMID; RAT;

ADENOVIRIDAE; ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEINS; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLLAGEN; GENETIC VECTORS; HUMANS; IMMUNOCOMPETENCE; MALE; MUSCLES; OSTEOGENESIS; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRIDAE; ANIMALIA;

EID: 3142731900     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/1043034041361208     Document Type: Article

References (31)

1. ALDEN, T.D., PITTMAN, D.D., HANKINS, G.R., BERES, E.J., ENGH, J.A., DAS, S., HUDSON, S.B., KERNS, K.M., KALLMES, D.F., and HELM, G.A. (1999). In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum. Gene Ther. 10, 2245-2253.
2. BALTZER, A.W.A., LATTERMANN, C., WHALEN, J.D., WOOLEY, P., WEISS, K., GRIMM, M., GHIVIZZANI, S.C., ROBBINS, P.D., and EVANS, C.H. (2000). Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of BMP-2 gene. Gene Ther. 7, 734-739.
3. BESSHO, K., TAGAWA, T., and MURATA, M. (1989). Purification of bone morphogeneic protein derived from bovine bone matrix. Biochem. Biophys. Res. Commun. 165, 595-601.
4. BONADIO, J., SMILEY, E., PATI, P., and GOLDSTEIN, S. (1999). Localized direct plasmid gene therapy in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5, 753-759.
5. CONNETRY, H.V., and BRIGGS, A.R. (1966). Determination of serum calcium by means of orthocresolphthalein complexone. Am. J. Clin. Pathol. 45, 290-296.
6. ENGSTRAND, T., DALUISKI, A., BAHAMONDE, M.E., MELHUS, H., and LYONS, K.M. (2000). Transient production of bone morphogenetic protein 2 by allogeneic transplanted transduced cells induces bone formation. Hum. Gene Ther. 11, 205-211.
7. FUJIMURA, K., BESSHO, K., KUSUMOTO, K., OGAWA, Y., and IIZUKA, T. (1995). Experimental studies on bone inducing activity of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2. Biochem. Biophys. Res. Commun. 208, 316-322.
8. IRVINE, K.R., CHAMBERLAIN, R.S., SHULMAN, E.P., SURMAN, D.R., ROSENBERG, S.A., and RESTIFO, N.P. (1997). Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors. J. Natl. Cancer Inst. 89, 1595-1601.
9. JOOSS, K., YANG, Y., and WILSON, J.M. (1996). Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Hum. Gene Ther. 7, 1555-1566.
10. JOOSS, K., TURKA, L.A., and WILSON, J.M. (1998). Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig. Gene Ther. 5, 309-319.
11. KANEGAE, Y., MAKIMURA, M., and SAITO, I. (1994). A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol. 47, 157-166.
12. KANEGAE, Y., LEE, G., SATO, Y., TANAKA, M., NAKAI, M., SAKAKI, T., SUGANO, S., and SAITO, I. (1995). Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23, 3816-3821.
13. KATAGIRI, T., YAMAGUCHI, A., KOMAKI, M., ABE, E., TAKAHASHI, N., IKEDA, T., ROSEN, V., WOZNEY, J.M., FUJISAWA, S.A., and SUDA, T. (1994). Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127, 1755-1766.
14. KINGSLEY, D.M. (1994). The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8, 133-146.
15. LIEBERMAN, J.R., DALUISKI, A., STEVENSON, S., WU, L., McALLISTER, P., LEE, Y.P., KABO, J.M., FINERMAN, G.A., BERK, A.J., and WITTE, O.N. (1999). The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J. Bone Joint Surg. Am. 81, 905-917.
16. MIYAKE, S., MAKIMURA, M., KANEGAE, Y., HARADA, S., SATO, Y., TAKAMORI, K., TOKUDA, C., and SAITO, I. (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. U.S.A. 93, 1320-1324.
17. OCHIYA, T., TAKAHAMA, Y., NAGAHARA, S., SUMITA, Y., HISADA, A., ITOH, H., NAGAI, Y., and TERADA, M. (1999). New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: The Minipellet. Nat. Med. 5, 707-710.
18. OCHIYA, T., NAGAHARA, S., SANO, A., ITOH, H., and TERADA, M. (2001). Biomaterials for gene delivery: Atelocollagen-mediated controlled release of molecular medicines. Curr. Gene Ther. 1, 31-52.
19. OKUBO, Y., BESSHO, K., FUJIMURA, K., IIZUKA, T., and MIYATAKE, S. (1999). Expression of bone morphogenetic protein-2 via adenoviral vector in C2C12 myoblasts induces differentiation into the osteoblast lineage. Biochem. Biophys. Res. Commun. 262, 739-743.
20. OKUBO, Y. BESSHO, K., FUJIMURA, K., KUSUMOTO, K., OGAWA, Y., and IIZUKA, T. (2000a). Effect of elcatonin on osteoinduction by recombinant human bone morphogenetic protein-2. Biochem. Biophys. Res. Commun. 269, 317-321.
21. OKUBO, Y., BESSHO, K., FUJIMURA, K., KONISHI, K., KUSUMOTO, K., OGAWA, Y., and IIZUKA, T. (2000b). Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites. Int. J. Oral Maxillofac. Surg. 29, 62-66.
22. OKUBO, Y., BESSHO, K., FUJIMURA, K., KUSUMOTO, K., OGAWA, Y., and IIZUKA, T. (2000c). Osteogenesis by recombinant human bone morphogenetic protein-2 at skeletal sites. Clin. Orthop. 375, 295-301.
23. OKUBO, Y., BESSHO, K., FUJIMURA, K., IIZUKA, T., and MIYATAKE, S. (2000d). Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. Biochem. Biophys. Res. Commun. 267, 382-387.
24. OKUBO, Y., BESSHO, K., FUJIMURA, K., KAIHARA, S., IIZUKA, T., and MIYATAKE, S. (2001). The time course study of osteoinduction by bone morphogenetic protein-2 via adenoviral vector. Life Sci. 70, 325-336.
25. SHEA, L.D., SMILEY, E., BONADIO, J., and MOONEY, D.J. (1999). DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17, 551-554.
26. SIEMENS, D.R., AUSTIN, J.C., HEDICAN, S.P., TARTAGLIA, J., and RATLIFF, T.L. (2000). Viral vector delivery in solid-state vehicles: Gene expression in a murine prostate cancer model. J. Natl. Cancer Inst. 92, 403-412.
27. SONOBE, J., BESSHO, K., KAIHARA, S., OKUBO, Y., and IIZUKA, T. (2002). Bone induction by BMP-2 expressing adenoviral vector in rats under treatment with FK 506. J. Musculoskeletal Res. 6, 23-29.
28. SULLIVAN, D.E., DASH, S., DU, H., HIRAMATSU, N., AYDIN, F., KOLLS, J., BLANCHARD, J., BASKIN, G., and GERBER, M.A. (1997). Liver-directed gene transfer in non-human primates. Hum. Gene Ther. 8, 1195-1206.
29. WU, D.P., GILKESON, G.S., ARMITAGE, J., REICH, C.F., and PISETSKY, D.S. (1990). Selective recognition of DNA antigenic determinants by murine monoclonal anti-DNA antibodies. Clin. Exp. Immunol. 82, 33-37.
30. YAMAGUCHI, A., KATAGIRI, T., IKEDA, T., WOZNEY, J.M., ROSEN, V., WANG, E.A., KAHN, A.J., SUDA, T., and YOSHIKI, S. (1991). Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell Biol. 113, 681-687.
31. ZHANG, H.G., ZHOU, T., YANG, P., EDWARDS, C.K., CURIEL, D.T., and MOUNTZ, J.D. (1998). Inhibition of tumor necrosis factor α decreases inflammation and prolongs adenovirus gene expression in lung and liver. Hum. Gene Ther. 9, 1875-1884.